Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer
Award amount
$211,400Program and phase
SBIR · Phase IAward year
2016Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ENCODIA INC
- Proposal award date
- 2016-09-05
- Contract end date
- 2018-04-30
- UEI
- XQMHALBLACC9
- Solicitation number
- PAR13-327
- Topic code
- 102
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- HT protein profiling with a Next-Gen Protein Assay (NGPA)
- Design and directed evolution of an 'Edmanase' enzyme for high-throughput peptide sequencing.
- Directed evolution of N-terminal amino acid binding proteins for application to protein sequencing
- Development of Engineered Trypsin for Proteomics Sample Prep.
- Development of Population Level Serotyping Technology and Antibody Profiling for Infectious Pathogens with focus on Influenza and SARS-CoV-2
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- MiREA, a mHealth intervention to Reduce Health Disparities by Improving Equitable Access to Mandated College Students with Problematic Alcohol and Marijuana Use
- Modex, a cloud-based, centralized health economic model marketplace to reduce costs and enhance equity in cancer
- Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas
- Allogeneic cell and gene therapy for neuroendocrine tumors
- Nanoparticle formulation of Mediator kinase inhibitor for the treatment of peritoneal ovarian cancer
Research funding history
8 SBIR/STTR records share this UEI (2016–2021). Reported award amounts total $6,255,660. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services